Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
Abstract
Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
Fields of Study & Subjects
Spondyloarthritis Studies and Treatments
Psoriasis: Treatment and Pathogenesis
Rheumatoid Arthritis Research and Therapies
Publication details
- Journal / source
- Vivli
- Publication date
- 12 February 2026
- Language
- EN
- Document type
- Dataset